<code id='3C80DD5B66'></code><style id='3C80DD5B66'></style>
    • <acronym id='3C80DD5B66'></acronym>
      <center id='3C80DD5B66'><center id='3C80DD5B66'><tfoot id='3C80DD5B66'></tfoot></center><abbr id='3C80DD5B66'><dir id='3C80DD5B66'><tfoot id='3C80DD5B66'></tfoot><noframes id='3C80DD5B66'>

    • <optgroup id='3C80DD5B66'><strike id='3C80DD5B66'><sup id='3C80DD5B66'></sup></strike><code id='3C80DD5B66'></code></optgroup>
        1. <b id='3C80DD5B66'><label id='3C80DD5B66'><select id='3C80DD5B66'><dt id='3C80DD5B66'><span id='3C80DD5B66'></span></dt></select></label></b><u id='3C80DD5B66'></u>
          <i id='3C80DD5B66'><strike id='3C80DD5B66'><tt id='3C80DD5B66'><pre id='3C80DD5B66'></pre></tt></strike></i>

          explore

          explore

          author:hotspot    Page View:717
          Cholesterol
          APStock

          Verve Therapeutics said Sunday that the first 10 people to receive a one-time treatment powered by a form of CRISPR called base editing showed reductions in bad cholesterol levels — study results that are preliminary but signal the potential for gene-editing treatments to benefit people with an inherited type of cardiovascular disease.

          Three of the study participants treated with potentially therapeutic doses of the Verve drug, called VERVE-101, showed  reductions in LDL-C levels of 39%, 48%, and 55%, respectively. The latter patient’s decline in so-called “bad” cholesterol was maintained for six months.

          advertisement

          The Verve-101 study results were presented at the American Heart Association conference and are the first data in patients from a therapy that uses base editing to change individual letters of DNA. Verve licensed the base-editing technology from Beam Therapeutics.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Medicare drug price lawsuits could be good politics for Biden
          Medicare drug price lawsuits could be good politics for Biden

          AdobeWASHINGTON—PharmaceuticalcompaniesaredoinganythingtheycantostopPresidentBiden’sMedicareprogramf

          read more
          Wildfire smoke exposes gaps in outdoor worker protections
          Wildfire smoke exposes gaps in outdoor worker protections

          ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

          read more

          New lesbian bars spark hope amid disappearing LGBTQ+ spaces

          3:35AviewofHenriettaHudsoninNewYorkCityonMay9,2020inNewYorkCity.JohnNacion/STARMAXviaAP,FILEAsLGBTQ+